Vir Biotechnology (VIR) Enterprise Value (2018 - 2025)
Historic Enterprise Value for Vir Biotechnology (VIR) over the last 8 years, with Q3 2025 value amounting to -$497.8 million.
- Vir Biotechnology's Enterprise Value rose 4523.02% to -$497.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$497.8 million, marking a year-over-year increase of 4523.02%. This contributed to the annual value of -$901.0 million for FY2024, which is 4043.21% up from last year.
- According to the latest figures from Q3 2025, Vir Biotechnology's Enterprise Value is -$497.8 million, which was up 4523.02% from -$598.7 million recorded in Q2 2025.
- Vir Biotechnology's 5-year Enterprise Value high stood at -$497.8 million for Q3 2025, and its period low was -$2.4 billion during Q4 2022.
- For the 5-year period, Vir Biotechnology's Enterprise Value averaged around -$1.3 billion, with its median value being -$1.1 billion (2024).
- Its Enterprise Value has fluctuated over the past 5 years, first crashed by 31949.74% in 2022, then skyrocketed by 4865.06% in 2024.
- Quarter analysis of 5 years shows Vir Biotechnology's Enterprise Value stood at -$565.0 million in 2021, then crashed by 319.5% to -$2.4 billion in 2022, then skyrocketed by 36.18% to -$1.5 billion in 2023, then soared by 40.43% to -$901.0 million in 2024, then surged by 44.75% to -$497.8 million in 2025.
- Its Enterprise Value was -$497.8 million in Q3 2025, compared to -$598.7 million in Q2 2025 and -$790.9 million in Q1 2025.